Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis

BACKGROUND: Interstitial pneumonia (IP) is one of the most common and poor prognostic comorbidities in patients with small cell lung cancer (SCLC). The pharmacotherapy for SCLC occasionally induces fatal acute exacerbation of comorbid IP, especially in patients with idiopathic pulmonary fibrosis (IP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Ikeda, Satoshi, Ogura, Takashi, Kato, Terufumi, Kenmotsu, Hirotsugu, Iwasawa, Tae, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238300/
https://ncbi.nlm.nih.gov/pubmed/32489433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920923431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados